"I have made the emergence and global growth of personalized health my mission, as it will fundamentally transform human life. My approach is to create bridges between technological innovation and real patient impact."
Tram is a Certified Independent Director and multicultural C-Suite executive with over 25 years of experience in transforming and scaling HealthTech, MedTech, and AI SaaS companies internationally. Specializing in critical transition leadership, she has orchestrated major restructurings, led $2-3 billion acquisitions, and successfully transformed business models across North America, Europe, and Asia.
As a trusted advisor to CEOs, investors, and boards of private and public companies, Tram excels in guiding organizations (Fortune 500, mid-cap, and startups) toward rapid international growth. She brings a holistic approach combining corporate governance, data-driven market insights, financial expertise, international commercial law, and operational management. Tram brings a range of diverse perspectives to the boardroom: corporate governance, deep market trends and customer insights, financial, international commercial law and general management lenses. She excels in collaborations, brings holistic data-driven customer voices and market insights to the boardroom, encourages a pro-active board mindset with positive risk governance, balancing new market growth opportunities and risk mitigation to protect company's assets, brand and reputation.
Welch Allyn (NYSE:BAX)
As CEO of the French subsidiary and member of the EMEA Executive Board, Tram comprehensively restructured commercial, product, logistics, and service operations. She orchestrated the complete sale and transition of the subsidiary to a new distribution structure, laying the foundation for the subsequent $2 billion acquisition by Hillrom, then Baxter.
Johnson & Johnson OCD EMEA (NYSE:JNJ)
As Executive Board member, she led marketing services, pricing strategies, and Lean Six Sigma consulting services for the division, boosting profitability and paving the way for the $3 billion global division spin-off to Carlyle Group. She was awarded twice in 2002 and 2005 the Johnson & Johnson standards of leadership achievement.
Vitanlink (Founder-President since 2013)
Tram has co-founded 4 companies and co-invested in 8 early-stage startups, mentored 50+ scale-ups from inception to growth, creating cumulative value exceeding €100 million. She collaborates closely with Private Equity and Venture Capital funds for rapid growth and strong governance. She provided strategic advisory, investment, board-level leadership services to 50+ CEOs and Boards, building a strong interdisciplinary international partners' network from research, academic to industry, accelerators, and NGOs to guide portfolio companies at critical inflection points.
Recent Appointment (November 2024)
Eurazeo Kurma Partners fund appointed her to the Management board of Smartcatch as the external CBO, a European Oncology MedTech company to lead critical scale-up phases supporting the CEO and full board.
She earned an MBA from McGill, an LL.M from King’s College London, an active US Certified Public Accountant license (CPA New Hampshire State Board of Accountancy), a certification in Private Company Governance from the PDA, and the Pearson Financial Times Non-Executive Director Diploma, which equips her with a multidisciplinary perspective on law, finance, business strategy and corporate governance. Tram, born as a French national has lived and worked in 15 cities globally and currently resides in Paris. She speaks French, English, Vietnamese and German.
